Endocrine Flashcards
Onset, peak, duration for lispro, aspart, glusiline
Onset: rapid
peak: 1 hr
total: 4 hrs
Onset, peak, duration for regular insulin
Onset: 30 mins
peak: 1-2 hrs
total: 6 hrs
Onset, peak, duration for NPH
Onset: 1 hr
peak: 4-6
total: 16 hrs
Onset, peak, duration for Detemir
Onset: 1 hr
peak: 12 hr
total: 20 hr
Onset, peak, duration of glargine
onset: 1 hr
NO PEAK
duration: 24 hr
Effects of Metformin
inhibits glucose prodxn
sensitizes insulin receptors
reduces gut glucose absorption
Drug class/effect of Glipizide and glyburide
sulfonylureas, promote insulin release (NIDDM)
side effects for Glipizide and glyburide
hypoglycemia
weight gain
drug/effect Nateglinide and repaglinide
Meglitinides, promotes insulin release
side effects for Nateglinide and repaglinide
hypoglycemia risk (biggest risk with repaglinide), weight gain
drug class/effect pioglitazone and rosiglitazone
thiazolidinediones, decrease insulin resistance
side effects of thiazolidinediones
heart failure d/t fluid retention (caution with pre-existing)
Upper respiratory infection (URI), HA, sinusitis, myalgia
bladder cancer w/ long term, high dose therapy
can promote ovulation in women
Indication for thiazolidinediones
type 2 diabetes, often a an add on to metformin
drug class/effect of acarbose and miglitol
alpha-glucosidase inhibitors, decrease absorption of carbs from GI tract, lessened post-prandial glucose rise
side effects of alpha-glucosidase inhibitors
Gi discomfort
decreased iron absorption (anemia risk)
long term can lead to liver dysfunction
Effects of dipeptidyl peptidase-4 inhibitors (gliptins)
increase incretin hormones –> increase in glucose-dependent insulin release, decreased glucagon release after meals
DDP-4 inhibitors (gliptins) side effects
Rare: pancreatitis, fatal hemorrhagic or necrotizing
Hypersensitivity rxns: anaphylaxis, angioedema, stevens-johnson sydrome
hypoglycenmia only when mixed with other agents
Side effects of SGLT inhibitors
Female genital tract infexns
UTIs
increased urination –> hypotension, dehydration
Glucagon-like receptor agonists (GLP-1) effects
mimics effects of incretins, causing decreased postprandial glucose rise
adverse effects of GLP-1 agonists
GI side effects, pancreatitis (rare)
Effects of Mylin mimetic
synthetic analong of amylin, causing decreased gastric emptying, and suppression of glucagon (decreased post-prandial glucose rise)
adverse effects of Mylin mimetic
hypoglycemia when combined with other drugs, nausea, injection site rxns (mild)
Indication for glucagon
hypoglycemia when IV glucose is unavailable (and pt is unable to eat)
effects of glucagon
glycogen –> glucose, stimulates liver glucose prodxn. Also relaxes GI smooth muscle
Indication and effect of somatostatin analogs and growth hormone receptor antagonists
for excess growth hormone (giantism, acromegaly), pituitary adenoma,
inhibits growth hormone release
Somatotropin (exogenous) uses
pediatric GH deficiency
pediatric short stature (if more than 2 standard deviations below the mean)
prader willi syndrome (only if low GH)
adult GH deficiency
adverse effects of somatostatin
hyperglycemia (esp w/ DM)